Antibody Discovery Market Size Worth USD 1.6 Billion in 2023 and Expected to Reach Over USD 6.2 Billion by 2035 | Roots Analysis

Global Antibody Discovery Market Overview

The antibody discovery market is growing rapidly to USD 1.6 billion in 2023 and is anticipated to be worth over USD 6.2 billion in 2035. It is estimated to grow at a compounded annual growth rate of 12% from 2023 to 2035.
The continuous growth of the antibody discovery market will likely result from the increasing requirement of antibody-based therapies for treating various types of diseases. Presently, over 160 monoclonal antibodies have been approved by the regulating authorities to be used for the treatment of a wide range of diseases, including chronic inflammatory diseases, cancer, infectious diseases and cardiovascular diseases. However, discovering the antibody is a stringent process, it requires screening, isolation of targeted antibodies and characterization. Sometimes, the antibody development fails during clinical trials, resulting in investment and time loss. To overcome these challenges, several pharmaceutical players have initiated strategic collaborations to streamline the antibody discovery process and bridge the gap between clinical trials and the commercialization of antibodies.

You Can Download Free Sample PDF Copy Of This Report At:
https://www.rootsanalysis.com/reports/213/request-sample.html

Key Report Takeaways
⬝ More than 160 players, present across the globe, claim to offer customized services to support antibody drug discovery operations; nearly 90% of these players offer the capability to provide hit generation services.
⬝ In the pursuit of building a competitive edge, service providers are actively upgrading their existing capabilities and adding new competencies to augment their respective portfolios and affiliated offerings.
⬝ Close to 300 antibody discovery technologies are currently available in the market, which can be utilized by antibody-drug developers to conduct various types of antibody discovery operations.
⬝ Platform providers are focusing on integrating advanced features into their respective platforms to augment their antibody discovery portfolios.
⬝ Considering the lucrative opportunities associated with the antibody discovery domain, investors have actively disbursed funds, amounting to over USD 10 billion, over the past three years.
⬝ Findings of our proprietary deal structure model suggest that to identify the most beneficial deal structure, IP owners should adopt scenario-based approaches while signing such agreements.
⬝ In recent years, there has been a significant increase in the number of out-licensing deals and the upfront and conditional payments received by antibody discovery technology developers.
⬝ The antibody discovery services market will likely grow at a CAGR of ~12% over the next 12 years, primarily driven by the revenues generated from hit generation services offered by the players in this domain.

Competitive Landscape of Antibody Discovery Market
Presently close to 140 companies are presently offering antibody drug discovery services. The majority of the pharmaceutical players active in the field provide services for hit generation, holding a significant share 43% in 2035. The market is well-fragmented into small, mid-size, and large players who offer antibody discovery services. Out of all technologies, phage display is the most common technology used for antibody discovery. The rising technology advancements and active participation of the market players will likely grow the antibody discovery market in the future.

Antibody Discovery Market Regional Outlook
Based on the geographical region, the antibody discovery market is well segmented into North America, Europe, Asia-Pacific, Latin America, the Middle East and North Africa, and the rest of the world. As we lead the antibody discovery market, North America is likely to capture a significant share of the market 31% by 2035 and the growth trend in this geographical region remains unchanged. It is worth highlighting here that the antibody discovery services provider in Asia-Pacific continues to evolve and is likely to grow faster during the foreseeable future. Furthermore, the emergence of new players in the antibody discovery market has become the primary reason for the market's growth in the upcoming years.
Antibody Discovery Market Key Players
Examples of the key companies engaged in the antibody discovery market (which have also been profiled in this market report; the complete list of the key players is included in the full report) include:
▪ Ablexis
▪ Creative Biolabs
▪ Genmab
▪ Harbour Biomed
▪ Immunome
▪ ImmunoPrecise antibodies
▪ Isogenica
▪ Kymab
▪ Ligand Pharmaceuticals
▪ Morphosys
▪ RD-Biotech
▪ Syd Labs
▪ Viva Biotech
▪ WuXi Biologics
It is worth mentioning that the ongoing strategic deals and research activities in the field will likely drive the antibody discovery marker during the forecast period. Examples of recent development and research activities that has taken place in the field are as follows:
⬝ In June 2023, ABTHerx announced the launch of advance Atlas™ Mice (a transgenic mouse-based antibody discovery platform) in order to support the production of antibody based therapies.
⬝ In June 2023, Sanyou Biopharmaceuticals (a leading China based company) launched the Sanyou Super Trillion Common Light Chain Antibody Discovery platform with an aim of supporting the discovery of various bispecific antibody formats.
⬝ In March 2023, Twist Bioscience announced the launch of its antibody discovery services platform under the Twist Biopharma Solution subsidiary. Twist Bioscience has also acquired Abveris, an antibody discovery CRO in 2022, to get hold of its hybridoma technology and single-cell screening methods.
To get market data, market insights, financial statements, and a comprehensive analysis of the Antibody Discovery Market, please contact sales@rootsanalysis.com

Antibody Discovery Market Segments
Based on the research, Roots Analysis has segmented the antibody discovery market according to the Type of Service Offered, Antibody Discovery Method, Type of Antibody Generated, Nature of Antibody Generated, Type of Therapeutic Area, and Type of Geographical Region.
▪ Antibody Discovery Market, By Type of Service Offered
⬝ Antigen Designing
⬝ Hit Generation
⬝ Lead Selection
⬝ Lead Optimization
⬝ Lead Characterization
▪ Antibody Discovery Market, By Antibody Discovery Method
⬝ Hybridoma Based
⬝ Library Based
⬝ Single Cell Based
⬝ Transgenic Animal Based
▪ Antibody Discovery Market, By Type of Antibody Generated
⬝ Monoclonal Antibodies
⬝ Bispecific Antibodies
⬝ Others
▪ Antibody Discovery Market, By Nature of Antibody Generated
⬝ Chimeric
⬝ Human
⬝ Humanized
⬝ Murine
▪ Antibody Discovery Market, By Type of Therapeutic Area
⬝ Cardiovascular Disorders
⬝ Immunological Disorders
⬝ Infectious Disorders
⬝ Neurological Disorders
⬝ Oncological Disorders
⬝ Others
▪ Antibody Discovery Market, By Geographical Region
⬝ North America
⬝ Europe
⬝ Asia
⬝ Latin America
⬝ Middle East and North Africa
⬝ Rest of the World

You Can Ask a Question About Antibody Discovery Market By Clicking On the Given Link:

https://www.rootsanalysis.com/reports/213/ask-question.html

To know More about Antibody Discovery Market
https://www.rootsanalysis.com/reports/antibody-discovery-services-and-platforms-market/213.html

Don't miss out on other interesting titles:

1. Flow Cytometry Service Market, 2022-2035
2. Gene Editing Beyond CRISPR Market, 2022-2035
3. ADC Cytotoxic Payloads / Warheads: Products and Services Market, 2021-2035

Contact US
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com
Web: https://www.rootsanalysis.com

Roots Analysis is a global leader in the pharma/biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists, and strategic investors for over a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serving our clients best.

This release was published on openPR.